| | NorthShore
Q3 2009 | National Average |
|
Acute Myocardial Infarction (Heart Attack Care)
|
|
|
|
 AMI-1 Aspirin at Arrival: % of acute myocardial infarction (AMI) patients without aspirin contraindications who received aspirin within 24 hours before or after hospital arrival.
|
100%
|
94%
|
|
AMI-2 Aspirin Prescribed at Discharge: % of acute myocardial infarction (AMI) patients without aspirin contraindications who are prescribed aspirin at hospital discharge.
|
100%
|
91%
|
|
AMI-3 ACEI or ARB for Left Ventricular Systolic Dysfunction: % of acute myocardial infarction (AMI) patients with left ventricular systolic dysfunction (LVSD) and without angiotensin converting enzyme inhibitor (ACEI) contraindications who are prescribed an ACEI at hospital discharge.
|
93.3%
|
88%
|
|
AMI-4 Adult Smoking Cessation Advice/Counseling: % of acute myocardial infarction (AMI) patients who smoke and who received advice or counseling to stop smoking
|
100%
|
92%
|
|
AMI-5 Beta Blocker Prescribed at Discharge: % of acute myocardial infarction (AMI) patients without beta blocker contraindications who are prescribed a beta blocker at hospital discharge.
|
100%
|
92%
|
|
AMI-8a PCI Received Within 90 Minutes of Hospital Arrival: % of eligible patients having a percutaneous cardiac intervention PCI within 90 minutes of arrival at the hospital
|
82.4%
|
67%
|
|
Heart Failure
|
|
|
|
HF-1 Discharge Instructions Received: % of eligible patients with heart failure receiving detailed instructions at discharge
|
97.4%
|
69%
|
|
HF-2 Left Ventricular Function Assessment: % of heart failure patients with documentation in the hospital record that left ventricular function (LVF) were assessed before arrival, during hospitalization, or planned for after discharge.
|
99.0%
|
87%
|
|
HF-3 ACE Inhibitor for Left Ventricular Systolic Dysfunction: % of heart failure patients with left ventricular systolic dysfunction (LVSD) and without angiotensin converting enzyme inhibitor (ACEI) contraindications who are prescribed an ACEI at hospital discharge.
|
94.2%
|
87%
|
|
HF-4 Adult Smoking Cessation Advice/Counseling: % of patients with heart failure who smoke and who received advice or counseling to stop smoking
|
100%
|
89%
|
|
Community Acquired Pneumonia
|
|
|
|
PN-2 Pneumococcal Vaccination: % of patients with community acquired pneumonia age 65 and older who were screened for pneumococcal vaccine status and were administered the vaccine prior to discharge, if indicated.
|
96.7%
|
78%
|
|
PN-3b Blood Cultures Performed Before First Antiobiotic Received: % of patients with community acquired pneumonia having blood culture tests performed before first antiobiotic received
|
100%
|
90%
|
|
PN-4 Adult Smoking Cessation Advice/Counseling: % of patients with community acquired pneumonia who smoke and who received advice or counseling to stop smoking
|
100%
|
85%
|
|
PN-6 Initial Antibiotic Selection for CAP in Immunocompetent Patients: % of patients with community acquired pneumonia whose initial antibiotic treatment was appropriate antibiotic
|
95.5%
|
87%
|
|
Surgical Infection Prevention (CABG, Other Cardiac, Colon, Hip and Knee Replacements, Hysterectomy, Vascular Surgeries)
|
|
|
|
SCIP-1 Prophylactic Antibiotic Received Within 1 Hour Prior to Surgical Incision: % of eligible surgical patients receiving prophylactic antibiotic (to prevent infection) within 1 hour prior to surgical incision
|
98.4%
|
84%
|
|
SCIP-2 Prophylactic Antibiotic Selection for Surgical Patients (Appropriate): % of eligible surgical patients who had an appropriate prophylactic antibiotic selected
|
99.6%
|
91%
|
|
SCIP-3 Prophylactic Antibiotics Discontinued Within 24 Hours After Surgery End Time: % of eligible surgical patients having prophylactic antibiotics discontinued within 24 Hours after the end of surgery
|
99.2%
|
82%
|
|
SCIP-VTE-1 Recommended VTE Prophylaxis: % of patients who received the recommended antibiotic prophylaxis.
|
98.8%
|
76%
|
|
SCIP-VTE-2 Received Appropriate VTE Prophylaxis: % of patients who received appropriate antibiotic prophylaxis.
|
96.5%
|
80%
|